<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Combining &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/combining/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 16 Oct 2026 19:25:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Combining &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Rethinking Remyelination: Why Brain Stimulation Plus Drugs May Crack Multiple Sclerosis Repair</title>
		<link>https://bioengineer.org/rethinking-remyelination-why-brain-stimulation-plus-drugs-may-crack-multiple-sclerosis-repair/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 16 Oct 2026 19:25:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[combination therapy]]></category>
		<category><![CDATA[Combining]]></category>
		<category><![CDATA[microglia]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Neuroinflammation]]></category>
		<category><![CDATA[Non-invasive]]></category>
		<category><![CDATA[non-invasive brain stimulation]]></category>
		<category><![CDATA[oligodendrocyte precursor cells]]></category>
		<category><![CDATA[Pharmacological]]></category>
		<category><![CDATA[remyelination]]></category>
		<category><![CDATA[stimulation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=423364</guid>

					<description><![CDATA[A new perspective argues that pairing non-invasive brain stimulation with pro-remyelinating drugs could target both oligodendrocyte differentiation and the hostile lesion microenvironment, offering a rational route beyond the translational failures of single-target therapies in multiple sclerosis.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">423364</post-id>	</item>
	</channel>
</rss>
